MEME STOCK: Prices

By Dr. David Edward Marcinko MBA MEd

SPONSOR: http://www.MarcinkoAssociates.com

***

***

According to the Daily Beast, First Lady Melania Trump was allegedly used as “window dressing” in a multi-million-dollar memecoin scheme that deceived investors and enriched its crypto creators, according to a lawsuit filed in federal court. The suit involves the $Melania coin, which the 55-year-old First Lady promoted to her social media on the eve of President Donald Trump’s inauguration in January, writing, “The Official Melania Meme is live! You can buy $MELANIA now.” Many of Trump’s supporters purchased the coin, pushing it to trade at an all-time high price of $13.73 apiece. $Melania was trading at less than 10 cents per coin by Wednesday—a staggering crash in value. Investors in the coin filed a federal class action lawsuit in April against Benjamin Chow, co-founder of crypto exchange Meteora, and Hayden Davis, co-founder of crypto venture capital firm Kelsier Labs, among others, WIRED reported Tuesday.

***

Meme stock prices have shown dramatic volatility, with the Roundhill MEME ETF reflecting sharp swings driven by retail investor sentiment and social media hype.

The phenomenon of meme stocks—equities that gain popularity through online communities rather than traditional financial metrics—has reshaped market dynamics since early 2021. Companies like GameStop and AMC became emblematic of this trend, as retail investors coordinated on platforms like Reddit to drive prices to unprecedented highs. To capture this movement, the Roundhill Meme Stock ETF (ticker: MEME) was launched, bundling popular meme stocks into a single investment vehicle.

The price history of the MEME ETF illustrates the volatility inherent in meme stock investing. In October 2025 alone, the ETF experienced dramatic fluctuations. On October 13, it closed at $10.85, marking a 14.57% gain from the previous day. Just three days later, on October 16, it dropped to $9.97, an 8.95% decline. These swings reflect the influence of social media sentiment, short squeezes, and speculative trading rather than company fundamentals.

Over the past year, the MEME ETF has seen a 74.5% decline, underscoring the risks of investing in stocks driven by hype rather than earnings or growth potential. Despite occasional rallies, the overall trend has been downward, with the ETF trading around $8.93 as of the latest close.

This price history highlights the speculative nature of meme stocks. While they can offer short-term gains, they are highly susceptible to rapid reversals. Investors drawn to meme stocks should be aware of the emotional and social dynamics that drive their prices, and consider whether such volatility aligns with their risk tolerance and investment goals.

In essence, meme stock price history is a story of community-driven market disruption, where traditional valuation models are often sidelined in favor of viral momentum.

The MEME ETF serves as a barometer for this cultural shift, capturing both the excitement and the instability of this new investing frontier.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Subscribe and Refer

***

***

DAILY UPDATE: Markets, Cue Health Down, Blue Kansas Part C and the FOMC

MEDICAL EXECUTIVE-POST TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?
© Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2024

REFER A COLLEAGUE: MarcinkoAdvisors@msn.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

***

CITE: https://www.r2library.com/Resource

Markets: Stocks dropped ever so slightly to end last week as investors tried to make sense of the big jobs report. Lots of jobs = good, but lots of jobs also = interest rates likely staying the same for awhile longer (more below). AMC had a rough day, tumbling 15% as the latest meme stock craze started to fizzle.

CITE: https://tinyurl.com/2h47urt5

Blue Kansas City Exiting MA Market by 2025 Due to ‘Regulatory Demands’

Blue Cross and Blue Shield of Kansas City (Blue KC) is leaving the Medicare Advantage (MA) market at the end of 2024, the insurer announced recently. The company blamed “heightened regulatory demands and rising market and financial pressures” for the decision but said it is still focused on employer-sponsored health plans, and Medicare supplement and Affordable Care Act plans in the state.

“We explored every alternative path for our MA members and are disappointed we must exit this line of business,” said Erin Stucky, Blue KC President and CEO, in a statement. “We value our MA members and are committed to providing uninterrupted, quality service to our current MA membership through the end of 2024.”

Source: Noah Tong, Fierce Healthcare [6/3/24]

CITE: https://tinyurl.com/tj8smmes

Cue Health, founded in 2010, started with great hopes as it promised a way to accurately test for Covid-19 without needing a lab. “We designed and developed a new molecular testing platform bringing lab complexity to an easy-to-use, portable device. Now you can get the best of lab molecular testing — speed, accuracy, and versatility – at home, the office, or on the go,” the company shared on its website. The company went public (with the ticker  (HLTH) ) in 2021 at $16 and rose to $20.55 and carried that massive $2.3 billion valuation. Through 2023 and into this year, Cue unsuccessfully tried to shore up operations, get new products to market, and find new capital.

In May, however, the FDA advised customers not to use two of its products at all because they did not deliver accurate results. Finally, its board and executives threw in the towel. On May 28th, the company announced it was ceasing operations and filed for bankruptcy in Delaware’s U.S. Bankruptcy Court. The company’s assets will be sold off at an undetermined date, and the proceeds will be distributed to creditors.       

***

Inflation data from the Fed meeting on Wednesday: Inflation data for May arrives in the morning, and it’s expected to show price growth held steady at 3.4% annually. In the afternoon, the FOMC will wrap up its meeting with a Jerome Powell press conference. The Fed is pretty much a lock to hold interest rates at their current level.

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

PRIVATE COMPANIES: Raising Capital is Hard ~ No Very Tough!

By Staff Reporters

SPONSOR: http://www.MARCINKOAssociates.com

***

***

The markets are down again and stocks continued their September slump with tech companies getting hit especially hard as investors fretted about another possible Fed rate hike because of data showing prices for manufacturing and services trending upward. It was a mixed bag for the meme stock faithful, with AMC hitting an all-time low after releasing a plan to sell new shares and GameStop rising after-hours thanks to better-than-expected sales last quarter.

MEME: https://medicalexecutivepost.com/2021/10/23/what-are-meme-stocks/

***

This all may demonstrate that private companies looking to fund growth in this high-interest rate environment are facing a tough time raising capital amidst falling valuations, according to a new Deloitte survey.

The problem is particularly acute for smaller companies. Many of the companies challenged by capital raising saw themselves putting out the “For Sale” sign within the next six months, which could lead to an M&A boom later this year.

CITE: https://www.r2library.com/Resource/Title/0826102549

“The No. 1 largest factor that people saw as a challenge or a barrier was a decrease in valuations of their business,” Wolfe Tone, vice chair and US and Global Deloitte Private leader, told CFO Brew. “Clearly, increasing interest rates and pricing was closely behind that. Liquidity challenges not far behind that.”

Private companies have been looking to raise capital to fund a range of growth initiatives; meeting talent needs and expanding tech capabilities are at the top of the list, Tone said. Not far behind was “increasing productivity and improving cost structures.”

VC FUNDING: https://marcinkoassociates.com/fmv-appraisals/

COMMENTS APPRECIATED

Thank You

***